US Broker Ratings

Edwards Lifesciences Corporation (EW) Stock Analysis: Unlocking an 18% Upside Potential in a Burgeoning Healthcare Sector

Edwards Lifesciences Corporation (NYSE: EW) stands as a prominent player in the healthcare sector, particularly within the medical devices industry. With a current market capitalization of..

Guardant Health, Inc. (GH) Stock Analysis: A Growth Powerhouse with a 6.81% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a frontrunner in the precision oncology sector, is making waves in the healthcare industry with its innovative diagnostic solutions. With a..

Integer Holdings Corporation (ITGR): Investor Outlook with a Promising 39% Potential Upside

Integer Holdings Corporation (NYSE: ITGR) stands at a pivotal moment for potential investors, boasting a robust market capitalization of $3.54 billion within the healthcare sector. Specializing..

UnitedHealth Group (UNH) Stock Analysis: Is There More to Gain Beyond a 2.23% Potential Upside?

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, commands a significant presence in the healthcare plans industry with a robust market capitalization of..

Teleflex Incorporated (TFX) Stock Analysis: Evaluating the 11.06% Potential Upside for Investors

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, specializes in the design, development, and supply of single-use medical devices used in critical care..

Cytokinetics (CYTK) Stock Analysis: A 25.75% Potential Upside with Innovative Muscle Treatments

Cytokinetics, Incorporated (NASDAQ: CYTK) is capturing the attention of investors with its promising therapeutic pipeline and a notable 25.75% potential upside based on analyst projections. With..

Krystal Biotech (KRYS) Stock Analysis: A 13% Upside Potential Amid Strong Revenue Growth

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the healthcare sector, particularly within the biotechnology industry. Headquartered in Pittsburgh, Pennsylvania, the company is rapidly gaining..

Novartis AG (NVS) Stock Analysis: Navigating a 3.07% Dividend Yield Amidst Market Volatility

Novartis AG (NVS), a Swiss healthcare giant, commands a market capitalization of $252 billion and operates in the drug manufacturing sector. While the company is a..

DexCom, Inc. (DXCM) Stock Analysis: A 53% Upside Potential with Strong Buy Ratings

DexCom, Inc. (DXCM), a prominent player in the healthcare sector specializing in medical devices, has captured investor attention with its innovative continuous glucose monitoring (CGM) systems...

Chemed Corp (CHE) Stock Analysis: Healthcare Giant with a 34.53% Potential Upside

Chemed Corp (CHE) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Cincinnati, Ohio, the company operates through..

Agilent Technologies, Inc. (A) Stock Analysis: Potential 8.16% Upside and Robust Revenue Growth

Agilent Technologies, Inc. (NYSE: A) presents a compelling opportunity for investors interested in the healthcare sector, specifically within the diagnostics and research industry. With a market..

Bio-Techne Corp (TECH) Investor Outlook: Navigating Growth with a 13.65% Potential Upside

Bio-Techne Corp (NASDAQ: TECH) stands out in the biotechnology sector with a robust market capitalization of $9.13 billion. As a prominent player in the healthcare industry,..

AstraZeneca PLC (AZN) Stock Analysis: 6.2% Potential Upside Fuels Investor Interest

AstraZeneca PLC (AZN), a stalwart in the healthcare sector, continues to capture investor attention with its robust market position and promising growth potential. Headquartered in Cambridge,..

Baxter International Inc. (BAX) Stock Analysis: A 27.56% Potential Upside with Dividend Yield of 3.10%

Baxter International Inc. (NYSE: BAX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

RadNet, Inc. (RDNT) Stock Analysis: Healthcare Diagnostics Firm Poised for Growth with a 12.3% Upside Potential

RadNet, Inc. (NASDAQ: RDNT) stands out in the healthcare diagnostics sector, offering promising growth potential for investors with a recent analyst consensus indicating a potential upside..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating the Biotech Terrain with a 68.40% Revenue Growth

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, continues to capture investor interest with its innovative approach to treating rare diseases. Headquartered in..

Option Care Health, Inc. (OPCH) Investor Outlook: Analyzing a 41.89% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a key player in the healthcare sector, specifically in medical care facilities, presents an intriguing opportunity for investors seeking growth..

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 21% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, has garnered significant attention from investors, and for compelling reasons. With a market..

Regeneron Pharmaceuticals (REGN) Stock Analysis: A 27.79% Upside Beckons Investors Amidst Biotechnology Innovations

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a heavyweight in the biotechnology sector, offers a compelling narrative for investors seeking exposure to groundbreaking medical innovations. With a market..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 31% Upside Potential in Transforming Organ Transplantation

TransMedics Group, Inc. (NASDAQ: TMDX), a prominent player in the healthcare sector, is pioneering advancements in organ transplant therapy. With a current market capitalization of $3.66..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds